sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 326-350 out of 1348.

<< < 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 > >>

Public Release: 29-Aug-2016
ESC Congress 2016
AMERICA: No benefit to detecting and treating extra-coronary lesions
In patients with high-risk coronary artery disease, an active strategy of detecting and treating asymptomatic multisite artery disease combined with intensive medical therapy did not improve two-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extra-coronary lesions, new research shows.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
European Heart Journal: Acute Cardiovascular Care
First European standards for management of heart attack patients launched today
The first European standards for the management of heart attack patients are launched today by the European Society of Cardiology-Acute Cardiac Care Association. The quality indicators for acute myocardial infarction are published in European Heart Journal: Acute Cardiovascular Care, ACCA's official journal, and presented at ESC Congress together with the results of the inaugural implementation.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
Lipoprotein apheresis: A new approach to refractory angina?
Initial investigation of patients with suspected coronary heart disease using functional imaging -- rather than guideline-directed care -- resulted in significantly less unnecessary angiography, according to results of the CE-MARC 2 trial.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
ODYSSEY ESCAPE: Alirocumab cuts apheresis rates in familial hypercholesterolemia
Patients who have heterozygous familial hypercholesterolemia, a condition that causes abnormally raised low-density lipoprotein cholesterol levels and premature cardiovascular disease, can significantly reduce or even eliminate their need for expensive and time-consuming apheresis treatments with the PCSK9 inhibitor alirocumab.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
OPTICARE trial: Enhanced cardiac rehab programs help heart attack patients
Enhanced cardiac rehabilitation programs that include a year of group or personal lifestyle and fitness coaching did not improve cardiovascular risk scores more than a standard three-month program in patients recovering from a heart attack.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
'Multiplicative' benefit of cholesterol and blood pressure-lowering on cardiovascular risk
Long-term exposure to the combination of even modestly lower LDL cholesterol and systolic blood pressure has the potential to 'dramatically reduce' a person's lifetime risk of cardiovascular disease, according to new findings reported at ESC Congress 2016.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
HIJ-PROPER trial -- Intensive cholesterol-lowering treatment: No significantly better outcomes
Survival and other cardiovascular outcomes were not significantly reduced with intensive treatment using a second-line cholesterol-lowering medication on top of a standard statin, compared to statin treatment alone in patients with acute coronary syndrome and dyslipidemia, investigators reported here.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
American Journal of Tropical Medicine and Hygiene
New research finds female mosquitoes can transmit Zika virus to their eggs and offspring
As the recent Miami outbreak of Zika virus, transmitted by the bite of female Aedes aegypti mosquitoes, prompts an all-out war on the pest, new research reveals that female mosquitoes can pass the virus on to their eggs and offspring, bolstering the need for larvicide use as an integral part of the effort to stop the spread of the virus.

Contact: Bridget DeSimone
bdesimone@burness.com
301-280-5735
Burness

Public Release: 28-Aug-2016
ESC Congress 2016
Shorter dual antiplatelet duration holds up in NIPPON
A short-term course of dual antiplatelet therapy is non-inferior to a longer course in patients who have undergone placement of a particular kind of drug-eluting stent, researchers reported here.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2016
ESC Congress 2016
SAVE: Sleep apnea treatment: No cardiovascular benefit
More than three years of nightly treatment with a continuous positive airway pressure machine did not reduce cardiovascular risk more than usual care among patients with cardiovascular disease and obstructive sleep apnea.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2016
ESC Congress 2016
ANTARCTIC trial antiplatelet monitoring: No benefit in elderly patients
Monitoring platelet function in order to individualize antiplatelet therapy did not improve outcomes for elderly patients after a heart attack compared to a standard, unmonitored approach, results of the ANTARCTIC trial show.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2016
ESC Congress 2016
Infused stem cells in heart failure: Improved health status but not cardiac function
A single dose of mesenchymal stem cells delivered intravenously to patients with chronic non-ischemic cardiomyopathy was not associated with significant cardiac structural or functional improvements, but did result in several clinically relevant benefits, according to results from a phase II-a randomized trial.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2016
ESC Congress 2016
CHART-1: Largest cardiac regenerative therapy trial brings new insights
A therapy that uses bone-marrow stem cells to promote heart repair did not significantly improve the primary outcome over a sham procedure among patients with congestive heart failure. However, it revealed critical new insights, according to investigators of the CHART-1 trial.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2016
ESC Congress 2016
JAMA
The REM-HF trial: Remote monitoring of implantable cardiac devices: No added benefit
For heart failure patients with cardiac implantable electronic devices (CIEDs), remote monitoring of their condition does not improve outcomes compared to usual care, according to Hot Line results presented at ESC Congress 2016 and to be simultaneously published in JAMA.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2016
ESC Congress 2016
New England Journal of Medicine
DANISH: No overall survival benefit with ICDs in non-ischemic heart failure
Placement of an implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure did not improve overall survival compared to usual clinical care -- although a secondary outcome, risk of sudden cardiac death, was halved with ICD placement, according to new research reported here.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2016
ESC Congress 2016
Sudden death in hypertrophic cardiomyopathy rarely associated with exercise
Sudden death in patients with hypertrophic cardiomyopathy (HCM) is rarely associated with exercise, according to research presented at ESC Congress 2016 today by Dr. Gherardo Finocchiaro, a cardiologist at St George's University of London, UK. Nearly 80 percent of patients in the study had no symptoms and only one in five had been diagnosed with HCM before their death.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2016
ESC Congress 2016
Mediterranean diet associated with lower risk of death in cardiovascular disease patients
The Mediterranean diet is associated with a reduced risk of death in patients with a history of cardiovascular disease, according to results from the observational Moli-sani study presented at ESC Congress 2016 today.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2016
ESC Congress 2016
Defibrillators could save many more lives if associated with basic life support education
Automatic external defibrillators fail to save lives when the public does not have basic life support education, according to research presented today at ESC Congress 2016. The study found that public access defibrillation programs are unevenly deployed across France, with an obvious impact on out-of-hospital cardiac arrest survival rate.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2016
ESC Congress 2016
Traffic accidents increased by 50 percent in patients with implantable cardioverter defibrillator
The risk of traffic accidents is increased by 50 percent in patients with an implantable cardioverter defibrillator compared to age and gender matched controls, according to a Danish nationwide registry study presented at ESC Congress 2016 today.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2016
ESC Congress 2016
Nebivolol prevents anthracycline-induced cardiotoxicity
Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2016
ESC Congress 2016
Increased risk of death for heart failure patients with each NHS hospital admission
Heart failure patients have a 2 percent increased risk of dying with each admission to NHS hospitals, according to research presented at ESC Congress 2016 today. The 15-year study in more than 450,000 patients from the ACALM Study Unit, Birmingham, UK, included 13,416 patients with heart failure.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2016
ESC Congress 2016
Heart failure in the elderly set to triple by 2060
Heart failure in the elderly is set to triple by 2060, according to new data from the Age, Gene/Environment Susceptibility (AGES) -- Reykjavík study presented at ESC Congress 2016 today.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2016
ESC Congress 2016
European Heart Journal
ESC launches novel paper on tackling cardiac toxicity of anticancer therapies
The European Society of Cardiology has launched a novel position paper, under the auspices of its Committee for Practice Guidelines, on tackling the cardiac toxicity of anticancer therapies. The cardio-oncology paper is published online today in European Heart Journal and on the ESC website.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2016
ESC Congress 2016
European Heart Journal
ESC/EAS guidelines for the management of dyslipidaemias launched today
European Society of Cardiology and European Atherosclerosis Society uidelines for the management of dyslipidaemias are published online today in European Heart Journal and on the ESC website.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2016
ESC Congress 2016
European Journal of Cardio-Thoracic Surgery
ESC and EACTS launch first collaborative atrial fibrillation guidelines
The first European Society of Cardiology Guidelines on Atrial Fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery are published online today in European Heart Journal and the European Journal of Cardio-Thoracic Surgery, and on the ESC website.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Showing releases 326-350 out of 1348.

<< < 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 > >>